225 related articles for article (PubMed ID: 26426760)
1. Emerging roles for the FBXW7 ubiquitin ligase in leukemia and beyond.
Kourtis N; Strikoudis A; Aifantis I
Curr Opin Cell Biol; 2015 Dec; 37():28-34. PubMed ID: 26426760
[TBL] [Abstract][Full Text] [Related]
2. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
[TBL] [Abstract][Full Text] [Related]
3. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
King B; Trimarchi T; Reavie L; Xu L; Mullenders J; Ntziachristos P; Aranda-Orgilles B; Perez-Garcia A; Shi J; Vakoc C; Sandy P; Shen SS; Ferrando A; Aifantis I
Cell; 2013 Jun; 153(7):1552-66. PubMed ID: 23791182
[TBL] [Abstract][Full Text] [Related]
5. Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.
Cao J; Ge MH; Ling ZQ
Medicine (Baltimore); 2016 Feb; 95(7):e2496. PubMed ID: 26886596
[TBL] [Abstract][Full Text] [Related]
6. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
7. Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.
Onoyama I; Suzuki A; Matsumoto A; Tomita K; Katagiri H; Oike Y; Nakayama K; Nakayama KI
J Clin Invest; 2011 Jan; 121(1):342-54. PubMed ID: 21123947
[TBL] [Abstract][Full Text] [Related]
8. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
[TBL] [Abstract][Full Text] [Related]
9. Regulation mechanism of Fbxw7-related signaling pathways (Review).
Zhou Z; He C; Wang J
Oncol Rep; 2015 Nov; 34(5):2215-24. PubMed ID: 26324296
[TBL] [Abstract][Full Text] [Related]
10. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.
Zhao J; Wang Y; Mu C; Xu Y; Sang J
Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460
[TBL] [Abstract][Full Text] [Related]
11. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice.
Onoyama I; Nakayama KI
Cell Cycle; 2008 Nov; 7(21):3307-13. PubMed ID: 18948752
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin ligase Fbxw7 controls adipocyte differentiation by targeting C/EBPalpha for degradation.
Bengoechea-Alonso MT; Ericsson J
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11817-22. PubMed ID: 20534483
[TBL] [Abstract][Full Text] [Related]
13. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.
Matsuoka S; Oike Y; Onoyama I; Iwama A; Arai F; Takubo K; Mashimo Y; Oguro H; Nitta E; Ito K; Miyamoto K; Yoshiwara H; Hosokawa K; Nakamura Y; Gomei Y; Iwasaki H; Hayashi Y; Matsuzaki Y; Nakayama K; Ikeda Y; Hata A; Chiba S; Nakayama KI; Suda T
Genes Dev; 2008 Apr; 22(8):986-91. PubMed ID: 18367647
[TBL] [Abstract][Full Text] [Related]
14. The emerging roles of F-box proteins in pancreatic tumorigenesis.
Wang H; Maitra A; Wang H
Semin Cancer Biol; 2016 Feb; 36():88-94. PubMed ID: 26384530
[TBL] [Abstract][Full Text] [Related]
15. MYC is a critical target of FBXW7.
Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J
Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969
[TBL] [Abstract][Full Text] [Related]
16. Fbxw7-dependent degradation of Notch is required for control of "stemness" and neuronal-glial differentiation in neural stem cells.
Matsumoto A; Onoyama I; Sunabori T; Kageyama R; Okano H; Nakayama KI
J Biol Chem; 2011 Apr; 286(15):13754-64. PubMed ID: 21349854
[TBL] [Abstract][Full Text] [Related]
17. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.
Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C
Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516
[TBL] [Abstract][Full Text] [Related]
18. Fbxw7 controls angiogenesis by regulating endothelial Notch activity.
Izumi N; Helker C; Ehling M; Behrens A; Herzog W; Adams RH
PLoS One; 2012; 7(7):e41116. PubMed ID: 22848434
[TBL] [Abstract][Full Text] [Related]
19. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF
Bajpai S; Jin HR; Mucha B; Diehl JA
Cancer Biol Ther; 2022 Dec; 23(1):348-357. PubMed ID: 35438057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]